Company intelligence / Profile preview

BioNeutral Laboratories

Newark, NJ, USA

Ownership: Private
Development stage: Other

Overview

BioNeutral Laboratories was a life science company focused on the development and commercialization of advanced antimicrobial and neutralizing technologies. The company's core platform was designed to eliminate a wide range of pathogens, including bacteria, viruses, and spores, while also neutralizing harmful chemical agents. Its flagship product, Ygiene, received EPA approval as a high-level disinfectant for use in healthcare, food service, and industrial environments. BioNeutral Laboratories aimed to provide environmentally friendly alternatives to traditional toxic disinfectants through its proprietary chemical formulations.

Therapeutic areas: Infectious Diseases
Modalities: Small molecule
Industry: Non-Drug Biotech

Partnerships

Rutgers University

Beyond the preview

Go deeper on BioNeutral Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioNeutral Laboratories.

Explore the full profile